Tobacco

Evaluating Alternative Tobacco Products

With over 20 years of experience conducting comprehensive Phase I-IIa clinical studies, Frontage Clinical Services has full-service capabilities to conduct a broad range of study types (e.g. PK, confinement and ambulatory). Because of our extensive experience with a wide variety of drug delivery systems, we are well-positioned to conduct tobacco-focused clinical research studies with endpoints including nicotine PK analysis, abuse liability and analysis of biomarkers of potential harm.

Frontage Full-Service Approach

Our modern 36,000 sq. ft. facility lo­cated in Secaucus, NJ includes a purpose-built, 160-bed clinic within multiple units, and specialized smoking and vaping rooms. We have a secure limited-access dedicated storage facility for investigational products, with video monitoring and restricted key card entry throughout the facility. Our staff includes 2 full time board-certified physicians serving as Investigators, and a laboratory manager, project manager and technical advisor with tobacco clinical research experience.

What sets us apart:

Clinical Services

Our clinical facility includes two separate specialized smoking/vaping rooms with:

• Air handling units utilizing displacement ventilation
• Convective air flows from floor to ceiling
• Adjoining dispensing rooms and processing laboratories
• Accommodations for up to 40 subjects at one time
• Furniture containing non-absorbent fabric for easy cleaning

Recruitment Capabilities For Tobacco Studies

Our clinical facility is in an ethnically diverse region in northern New Jersey:

• Less than 7 miles from NYC, with access to over 3 million healthy adult volunteers who self-report as smokers
• Proximity to extensive mass transit and major airports
• Located in medical center hub, giving access to large pool of trained medical staff.

Bioanalysis And Research Services

Tobacco Specific Assays: We are developing a variety of assays tailored to meet your needs in matrices such as human serum, plasma, and urine.

• Biomarkers of Exposure
• Biomarkers of Biological Effect (Biomarkers of Potential Harm)

If you are interested in Tobacco Specific Biomarkers, please click here!